Search

ISSN: 2228-5881 eISSN: 2251-7308

Adv Pharm Bull. 2023;13(2): 399-407. doi: 10.34172/apb.2023.044

PMID: 37342374 PMCID: PMC10278226

Research Article

New Prospective Phosphodiesterase Inhibitors: Phosphorylated Oxazole Derivatives in Treatment of Hypertension

Iryna V. Nizhenkovska ¹ , Kateryna V. Matskevych ¹ * , Oksana I. Golovchenko ¹ , Oleksandr V. Golovchenko ² , Antonina D. Kustovska ³ , Mikhaeel Van ¹

Cited by CrossRef: 1

1- Bahrieieva O, Golovchenko O, Golovchenko O, Zhirnov V, Brovarets V. New phosphorylated 5-(hydroxyalkylamino)-1,3-oxazoles as potential anticancer agents. Ukr Bioorg Acta. 2023;18(1):32 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Indexing Info About APB & Contacts Indexing and Abstracting Articles In Press Archive

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308
pISSN: 2228-5881

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by

Abstracting and Indexing

PubMed Central, Pubmed,

Emerging Sources Citation Index

Scopus, Google Scholar,

EMBASE/Excerpta Medica

EBSCOhost; CAS: DOAJ

SCImago Journal & Country Rank